Extrapulmonary benefits and pharmacogenomics in lung transplant recipients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy.

Kennedy JC, Taddesse AA, Coppolino A, Lee SE, Dahlberg SE, Perkins RC, Cagnina RE, Sheikh A, Cernadas M, Jacob SS, Kear K, Kubiak S, Zhang Y, Keshk MA, Hackmann AE, Lee SF, Fieg E, Algarawi A, Ito EK, Kerman BJ, Woolley AE, Washko GR, Goldberg HJ, Raby BA, Uluer AZ

Open source

DOI: 10.1016/j.jcf.2026.09.007
Published: 2026 Sep 26
Container: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jcf.2026.09.007,
  title = {Extrapulmonary benefits and pharmacogenomics in lung transplant recipients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy.},
  author = {Kennedy JC and Taddesse AA and Coppolino A and Lee SE and Dahlberg SE and Perkins RC and Cagnina RE and Sheikh A and Cernadas M and Jacob SS and Kear K and Kubiak S and Zhang Y and Keshk MA and Hackmann AE and Lee SF and Fieg E and Algarawi A and Ito EK and Kerman BJ and Woolley AE and Washko GR and Goldberg HJ and Raby BA and Uluer AZ},
  year = {2026},
  journal = {Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
  doi = {10.1016/j.jcf.2026.09.007},
  url = {https://doi.org/10.1016/j.jcf.2026.09.007}
}

RIS

TY  - JOUR
TI  - Extrapulmonary benefits and pharmacogenomics in lung transplant recipients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy.
AU  - Kennedy JC
AU  - Taddesse AA
AU  - Coppolino A
AU  - Lee SE
AU  - Dahlberg SE
AU  - Perkins RC
AU  - Cagnina RE
AU  - Sheikh A
AU  - Cernadas M
AU  - Jacob SS
AU  - Kear K
AU  - Kubiak S
AU  - Zhang Y
AU  - Keshk MA
AU  - Hackmann AE
AU  - Lee SF
AU  - Fieg E
AU  - Algarawi A
AU  - Ito EK
AU  - Kerman BJ
AU  - Woolley AE
AU  - Washko GR
AU  - Goldberg HJ
AU  - Raby BA
AU  - Uluer AZ
PY  - 2026
JO  - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
DO  - 10.1016/j.jcf.2026.09.007
UR  - https://doi.org/10.1016/j.jcf.2026.09.007
ER  -

APA

JC, K., AA, T., A, C., SE, L., SE, D., RC, P., RE, C., A, S., M, C., SS, J., K, K., S, K., Y, Z., MA, K., AE, H., SF, L., E, F., A, A., EK, I., BJ, K., AE, W., GR, W., HJ, G., BA, R., & AZ, U. (2026). Extrapulmonary benefits and pharmacogenomics in lung transplant recipients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy.. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2026.09.007

Source records

pubmed · retrieved 2026-09-27T09:50:38.159Z